Medtronic's recent regulatory approvals should bode well for non-GAAP EPS growth in the coming years. Read why I am ...

Notably, Medtronic holds the esteemed designation of a Dividend Aristocrat for investors who prioritize reliability. This ...

Medtronic offers a compelling long-term investment opportunity with solid revenue and earnings growth, driven by innovation ...

The US Food and Drug Administration (FDA) has granted approval for the use of Medtronic’s disposable Simplera Sync sensor ...